Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Novel splice-site variant of UCHL1 in an Indian family with autosomal recessive spastic paraplegia-79


Spastic Paraplegia-79 (SPG79) is an autosomal recessive type of childhood onset complicated by hereditary spastic paraplegia. SPG79 is characterized by spasticity, paraplegia, optic atrophy, cerebellar signs, and other variable clinical features. Recessive, disease causing variants in Ubiquitin C-terminal hydrolase-L1 (UCHL1) gene have been implicated as a cause for SPG79 in two families till now. In this study, we report on a third family of SPG79 with two similarly affected siblings, harboring a novel homozygous splice-site variant in the UCHL1 gene (NM_004181.4: c.459+2T>C). The variant was identified by whole-exome sequencing and validated by Sanger sequencing in the family.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2


  1. 1.

    Rydning SL, Backe PH, Sousa MML, Iqbal Z, Oye A-M, Sheng Y, et al. Novel UCHL1mutations reveal new insights into ubiquitin processing. Hum Mol Genet. 2017;26:1031–40.

    Article  PubMed  CAS  Google Scholar 

  2. 2.

    Bilguvar K, Tyagi NK, Ozkara C, Tuysuz B, Bakircioglu M, Choi M, et al. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration. Proc Natl Acad Sci USA. 2013;110:3489–94.

    Article  PubMed  Google Scholar 

  3. 3.

    Das Bhowmik A, Dalal A. Whole exome sequencing identifies a novel frameshift mutation in GPC3 gene in a patient with overgrowth syndrome. Gene. 2015;572:303–6.

    Article  PubMed  CAS  Google Scholar 

  4. 4.

    Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–2.

    Article  PubMed  CAS  Google Scholar 

  5. 5.

    Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. 6.

    Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. 7.

    Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science. 1989;246:670–2.

    Article  PubMed  CAS  Google Scholar 

  8. 8.

    Doran JF, Jackson P, Kynoch P, Thompson RJ. Isolation of PGP 9.5, a new human neurone-specific protein detected by high resolution two-dimensional electrophoresis. J Neurochem. 1983;40:1542–7.

    Article  PubMed  CAS  Google Scholar 

  9. 9.

    Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr. The UCHL1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson’s disease susceptibility. Cell. 2002;111:209–18.

    Article  PubMed  CAS  Google Scholar 

  10. 10.

    Osaka H, Wang Y-L, Takada K, Takizawa S, Setsuie R, Li H, et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet. 2003;12:1945–58.

    Article  PubMed  CAS  Google Scholar 

  11. 11.

    Zhang M, Cai F, Zhang S, Zhang S, Song W. Overexpression of ubiquitin carboxyl terminal hydrolase L1 (UCHL1) delays Alzheimer’s progression in vivo. Sci Rep. 2014;4:7298.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. 12.

    Ragland M, Hutter C, Zabetian C, Edwards K. Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson’s disease: a HuGE review and metaanalysis. Am J Epidemiol. 2009;170:1344–57.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Liu Y, Chen YY, Liu H, Yao CJ, Zhu XX, Chen DJ, et al. Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson’s disease: the impact of ethnicity and onset age. Neurol Sci. 2015;36:179–88.

    Article  PubMed  CAS  Google Scholar 

  14. 14.

    Butterfield DA, Gnjec A, Poon HF, Castegna A, Pierce WM, Klein JB, et al. Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer’s disease:an initial assessment. J Alzheimers Dis. 2006;10:391–7.

    Article  PubMed  CAS  Google Scholar 

  15. 15.

    Chen F, Sugiura Y, Myers KG, Liu Y, Lin W. Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction. Proc Natl Acad Sci USA. 2010;107:1636–41.

    Article  PubMed  Google Scholar 

Download references


We thank the families who cooperated with the evaluation of the subjects and consented for participation in this study.


This work was supported by Science and Engineering Research Board (SERB), Government of India (SERB file no. YSS/2015/001681).

Author information



Corresponding author

Correspondence to Ashwin Dalal.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Das Bhowmik, A., Patil, S.J., Deshpande, D.V. et al. Novel splice-site variant of UCHL1 in an Indian family with autosomal recessive spastic paraplegia-79. J Hum Genet 63, 927–933 (2018).

Download citation

Further reading


Quick links